Macrophage Metabolic Reprogramming in Inflammatory Bowel Diseases: From Pathogenesis to Therapy

Area of Science:

• Gastroenterology
• Immunology
• Metabolic Research

Background:

• Inflammatory bowel disease (IBD), including ulcerative colitis and Crohn's disease, is a chronic gastrointestinal disorder with increasing incidence.
• Current IBD treatments like anti-inflammatories, immunosuppressants, and biologics have potential adverse effects.
• Research is exploring novel therapeutic targets, particularly focusing on macrophage immune metabolism.

Purpose of the Study:

• To review the role and mechanisms of macrophage metabolic reprogramming in IBD.
• To explore the connection between macrophages and ferroptosis in the context of IBD.
• To discuss potential therapeutic strategies targeting macrophage metabolism and ferroptosis for IBD.

Main Methods:

• Literature review focusing on preclinical models and existing research.
• Analysis of the interplay between macrophage metabolism, immune function, and IBD pathogenesis.
• Examination of the link between macrophages and ferroptosis in gastrointestinal inflammation.

Main Results:

• Macrophage immune metabolism is significantly implicated in IBD, although precise mechanisms require further elucidation.
• Ferroptosis, a form of regulated cell death, is linked to macrophage function in IBD.
• Preclinical findings suggest targeting macrophage metabolic reprogramming and ferroptosis as potential therapeutic avenues.

Conclusions:

• Macrophage metabolic reprogramming and ferroptosis represent promising, yet speculative, therapeutic targets for IBD.
• Further rigorous, disease-specific validation in clinical settings is essential before these approaches can be widely applied.
• Understanding macrophage metabolism is key to developing innovative IBD treatments.